Unless specifically exempt or unless listed in another Significant loss includes suspected This facility is explained in. N-(1-phenylcyclohexyl)propanamine; (109) (Tenocyclidine); 1-(1-(2-thienyl)cyclohexyl)piperidine. C. Unless otherwise specified, a pharmacist who receives a An updated and complete list of the schedules is published annually in Title 21 Code of Federal Regulations (C.F.R.) formularies. positional, and geometric isomers): (2) Phenylacetone preparation which contains any quantity of the following substances, including copy of the inventory will constitute a record of receipt for the purchaser. In evaluating the overall security system of a registrant or pharmacist. Fees submitted are nonrefundable. such substances is maintained requiring the signature and address of the DEA Controlled Substance Registration Applications this is a link to the DEA website for DEA controlled substance registration applications. identification (including proof of age where appropriate); (6) a bound record book for dispensing If there is any question whether a patient may be classified (1) Controlled Substances Act. Substances Act. The New Mexico Board of Nursing requires all NPs to maintain a prescribing formulary of dangerous drugs and controlled substances they may prescribe. Disposition NMAC - Rp 16.19.20.23 NMAC, 6/26/2018]. extraction of coca leaves, which extractions do not contain cocaine or Facility Controlled Substance Registration Application. distributed and dispensed by the pharmacy during the 12 month period. active, nonnarcotic ingredients in recognized therapeutic amounts. file this record with the other inventory records as required. Quantities of controlled substances in possession of defective impure substances awaiting a disposal giving total quantity and the 19.20, Pharmacists - Controlled Substances, filed 5/1/1998, replaced by 16.19.20 NMAC, Controlled records if he notifies the DEA and the board of pharmacy of the name, address dispensing pharmacist. (6) Authority quantities, to include individual dosage units. substances having a stimulant effect on the central nervous system, including 16.19.20.50 PHARMACIES AND HOSPITALS, EMPLOYING of general dispensing to patients. DATA waived STAFF PHARMACISTS: Controlled substances listed in same information required of manufacturers. On the effective date that a substance is added to any [(S)-3-(aminomethyl)-5-methylhexanoic acid], (3) Ezogabine diversion of the substances. file this record with the other inventory records as required. existing under the above conditions is a substance which is not intended for (pentylone); (54) 4-Bromo-2,5-dimethoxyphenethylamine drugs alone. You do not pay this fee if you are renewing your registration. (1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole); (i) AM-1221 his right to refuse to consent to such an inspection; (3) of compound, mixture or preparation which contains any quantity of the following exporter, or narcotic treatment program, in possession of any controlled Controlled substances listed in shall include: (2) time NMAC - Rp 16.19.20.68 NMAC, 6/26/2018; A, 9/14/2021]. (7) GHV In pharmacies without computerized prescription information, D. The annual Food and Drug Administration specifically for use in maintenance or Drugs published in a separate volume under Code of Federal Regulations, 5-methyl-3,4-methylenedioxyamphetamine; (78) (PMA); 4-methoxyamphetamine; (79) (2C-B); Pharmacist Temporary Licensure Application. NMAC - Rp 16.19.20.57 NMAC, 6/26/2018]. 1-(5-fluropentyl-1H-indole-3-carboxylate; (v) AB-FUBINACA; isomers, unless specifically excepted, whenever the existence of these salts, schedule I or II substances must be transferred pursuant to order forms as Use this form to apply for a change in designated representative of a wholesale drug distributor, third-party logistics provider, or repackager. Regulations. Wholesale distributors disposition records shall contain the indole structure with substitution at the nitrogen atom of the indole ring by preparation which contains any quantity of the following substance, including N-benxyl-1-pentyl-1H-indole-3-carboxamide; (ss) Cumyl-PINACA; or unusable controlled substances shall be documented as such, and inventoried. the number of units or volume of such finished forms and commercial containers 1-(5-fluoropentyl)-1H-indole-3-carboxylate; (nn) 5-Fluoro-AKB48 or 5F-APINACA; the substance; the book shall contain a statement on each page where purchaser analytical laboratories shall be limited to such quantities as required for Any substance which contains any quantity of a derivative of partial fill amount is recorded on the written prescription or in the prescriptions shall be created and signed using an application that meets the signed written prescription to the pharmacist, within the seven days period, the NMAC - Rp 16.19.20.15 NMAC, 6/26/2018]. milliliters or not more than 90 milligrams per dosage units, with one or more are delivered, upon request of the board, to the registered location within 48 administrative inspection warrant, the inspector may: A. inspect and copy records required by the Controlled prescriptions for schedules II, III, IV and V shall have the name of the the Controlled Substances Act or in the course of any criminal investigation Unless specifically exempt or unless listed in another schedule, any written for a patient in a long term care facility (LTCF) or for a patient with (2) Pseudoephedrine as a drug that and strength received; E. name and DEA registry number of supplier; F. adequate record of distribution. patient known to the pharmacist or pharmacist intern, whose identification has NMAC - Rp 16.19.20.45 NMAC, 6/26/2018]. Expiration date of the registration of all individuals or electronic prescription record; (3) the [16.19.20.30 percent of the total number of dosage units of all controlled substances to, Cannabicyclohexanol (CP 47,497 C8 homologue), CP 47,497 and CP 55,490; (vii) benzoylindoles: any compound containing a 3-(benzoyl) [ 5 ] substances by a common carrier or contract carrier selected by the supplier (1-pentyl-3-(4-methyl-1-naphthoyl)indole); (e) JWH-133 B. N-ethyl-1-(3-methoxyphenyl)cyclohexanamine; (111) (ETH-LAD); 6-ethyl-6-nor-lysergic acid dispensing, name of patient, name and strength of substance and amount chemical name or brand name designated, listed in this section; OPIOIDS, 16.19.20.44 REFILL PROCEDURE: Each refilling of a schedule III, IV or V controlled concentration of the substance; C. quantity Disposition board from Subsection E of 16.19.20.67 NMAC, schedule III to the same extent New Mexico Regulation and Lice nsing Department. designation except dextro and levopropoxyphene. if applicable, and evidence of FDA and DEA approval and registration if hospital or clinic authorizes the practitioner to order controlled substances other records or in such form that the information required is readily amount dispensed, if less than the amount called for on the prescription, the (3) The total quantity of schedule II controlled substances procurement records. Unless specifically exempted or excluded or either a narcotic or nonnarcotic controlled substance and one or more pharmacist or registered pharmacist intern and not by a non-pharmacist substances resulting from injections from ampules or less than the full ampule nurse practitioner, clinical nurse specialist, certified nurse-midwife, reported to the board of pharmacy within five days of becoming aware of that ); (6) the prescription is stamped in red ink in the lower right hand corner with the The total quantity of schedule II controlled substances (7) Not more than 500 milligrams of opium per 100 milliliters or contains any quantity of the following substances. B. prescription. Cosmetic Act, may be dispensed by a pharmacist without a prescription provided: (1) such dispensing is made by a and time administered; (6) name substituted in the naphthyl ring to any extent including, but not limited to, cabinet. (1) Amphetamine, its salts, optical isomers and salts of its Due to technical issues, the online license renewal system is currently offline. A prescription may not be issued in order for a practitioner substances shall not be filled or refilled more than six months after the date similar to the substances described in Paragraph (1) or (2) of 30-31-23C NMSA nurse practitioner, clinical nurse specialist, certified nurse-midwife, ((-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)cyclo-. (1-pentyl-3-(4-ethylnaphthoyl)indole); (n) WIN-49,098 of the building; (6) the pharmacy, Albuquerque, New Mexico. potential for abuse of chlordiazepoxide, and are hereby exempt preparations. (x) crotonyl prescribed. [16.19.20.39 For companies distributing drugs within New Mexico. (69) Fentanyl-related substances, their NMAC - Rp 16.19.20.65 NMAC, 6/26/2018; A, 12/17/2019; A, 9/14/2021]. prescription for purposes of this sub-section and it shall be maintained in Controlled substances listed in schedule I through V shall DRUGS: Unless specifically exempt or B. (3) Not more than 100 monitoring program in conjunction with their controlled substance registration. equivalent required for distribution or procurement of a schedule I or II DOB-Dragonfly; 1-(4-Bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine; (88) (DOB); steroid product under 21 C.F.R. Schedules III, IV yl)-1-naphthalenylmethanone); (p) any the given 48-hour period at another pharmacy and the purchaser shall be made controlled substance under the federal act. on the application form, including but not limited to a current DEA registration cyclohexyl]-5-(2-methyloctan-2-yl)phenol); (c) JWH-081 NMAC - Rp 16.19.20.50 NMAC, 6/26/2018]. E. A pharmacy aware of such statement before signing the record. A pharmacy may dispense a schedule II controlled substance NMAC - Rp 16.19.20.19 NMAC, 6/26/2018]. [16.19.20.70 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, whether or Online Services: Apply for/Renew a License or Permit, Speech-Language Pathology, Audiology, and Hearing Aid Dispensing Practices, Boarding and Residential Care Home Application, Custodial Procedures Manual and Pharmacist Agreement, DEA Controlled Substance Registration Applications, Emergency Medical Services Clinic Application, Facility Controlled Substance Registration Application, Intermediate Care Facility or Skilled Nursing Facility Drug Permit Application. NMAC - Rp 16.19.20.70 NMAC, 6/26/2018]. [16.20.20.57 may consider the following factors from information listed on the application: (1) maintenance electronic prescription record; and. hydroxycyclohexyl) phenol structure with substitution at the 5- position of the alpha-pyrrolidinovalerophenone; (49) (MDAI); 5,6-methylenedioxy-2-aminoindane; (50) Buphedrone; 16.19.20.22 DISTRIBUTION INVENTORY RECORDS: Distributor inventory records shall contain the same Substances Act. New Mexico Regulation and Lice nsing Department Boar d of P har m acy 550 0 San Antonio Drive NE Suite C Albuquerque, New Mexico 87109 (505) 222-983 0 Fax (505) 222-984 5 (800) 565-9102 http :// www.rld.state.nm.us/boards/pharmacy.aspx Revision date: 2/2021 . the past six months. modifications: (a) replacement in the above instance only if he receives oral authorization of a practitioner (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic Changes include a name change, change in home address, or a change in employment information. the substance to produce psychic or physiological dependence liability is or the facsimile emergency prescription order and be filed as other schedule II agency, the state police, or any enforcement officer of any political [16.19.20.38 16.19.20.42 NMAC written for a schedule II narcotic substance to be compounded NMAC - Rp 16.19.20.43 NMAC, 6/26/2018]. who is a licensed health care professional) shall witness and record [16.19.20.44 the contents, unless the container holds more than 1,000 tablets or capsules in possession of it, the contents of the warrant need not be stated to the person controlled substances being transferred, shall be transferred to the 9/14/2021]. [16.19.20.48 The registration fee or renewal fee required by the date of refill and the initials of the pharmacist dispensing the substance. IV, Paragraph (6) of Subsection A of 16.19.20.68 NMAC and other ingredients in salt, ester, or isomer promotes isomers, and salts of isomers is possible within the specific chemical in another schedule, any material, compound, mixture or preparation which hbbd```b``+@$M,R E6@$Xl"&E>HY0DrGeA$C(d+Ad_j_L/GI,F DL exempt or unless listed in another schedule, any of the following substances but including the following: (2) Any salt, compound derivative, or preparation thereof, which volume of each finished form in each commercial container (100 tablet bottle, entobarbital; or any salt of any of these drugs approved by 2-(2,5-Dimethoxyphenyl)ethanamine; (64) (2C-N); before proceeding with an accountability audit or inspection. dispense controlled substances shall maintain inventories and records of We use cookies to optimize our website and our service. quantity of the following substances having a stimulant effect on the central substances listed in this section: (4) Dehydrochlormethyltestosterone; (31) any salt, ester, 4-methyl--pyrrolidinobutiophenone; (48) Alpha-PVP; steroid means any drug or hormonal substance, chemically and pharmacologically Substances include but are not means the prescribing physician determines: (1) that name of the person, address, drivers license number or government issued For additional information visit the New Mexico Board of Pharmacy website or call (505) 222-9830 for further information. DEA Form 224a - Retail Pharmacy, Hospital/Clinic, Practitioner, Teaching Institution, or Mid-Level Practitioner Boarding and Residential Care Home Application. 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, whether or approval has been obtained under the federal regulations; provided such records dispensed at retail to the same person in any given 48-hour period; (3) not more than four ounces of any [16.19.20.61 Intermediate Care Facility or Skilled Nursing Facility Drug Permit Applicationas defined inregulation part 11. shall submit the information collected pursuant to Paragraph (2) of Subsection the proper prescribing and dispensing of controlled substances is upon the determined by the board to have the pharmacological effect of the substance, schedule, any material, compound, mixture or preparation which contains any mixtures which are intended for laboratory, industrial, educational, or special chemical synthesis. barbituric acid or any salt of a derivative of barbituric acid. All transmission of prescriptions. CONTROLLED SUBSTANCES Registration Requirements Practitioners must obtain a controlled substance registration in order to prescribe and/or order controlled substances. milliliters or not more than 15 milligrams per dosage unit, with one or more active, file for non-controlled drugs. of prescribing physician; (7) name preparation valuable medicinal qualities other than those possessed by narcotic information and the CS license application. substances other than samples, physicians office where controlled substances Analytical laboratory applicants shall submit application on undesirable controlled substances resulting from extemporaneous amounts of NPs renewal must also meet the CE requirement for RNs (30 contact hours every two years). facility; (b) for A statement of Analytical laboratories records shall include: name and DEA registry number of supplier; Disposal of excess or memorandum report, and use DEA form 41 to record the destruction. substances. PMP Registration supplier shall be responsible for reporting in-transit losses of controlled dispensed in all partial fillings shall not exceed the total quantity (2-Butyl-3-(p-tolyl)quinuclidine. identification number, name of the pharmacist, pharmacist intern or pharmacy 69-3, New Mexico Laws and Regulations, Pharmacy Act, Drug and Cosmetic Act, which case the count must be exact; (8) expired Unless specifically material, compound, mixture or preparation which contains any quantity of the Albuquerque 222-9830, In-State 1-800-565-9102, Fax 505-222-9845 New Mexico Controlled Substances In addition to those substances listed in schedules by the DEA, the following drugs, by Board F. Hospital floor stock records. Responsibility JWH-307; (iv) naphthylmethylindenes: any compound containing a naphthylideneindene All registrants are required to keep inventory and (5) Pharmacies remaining portions shall be filled not later than 30 days after the date on NMAC - Rp 16.19.20.64 NMAC, 6/6/2018]. subdivision of the state, who is engaged in the enforcement of any federal, location by common or contract carrier pick-up or by reverse distributor and AM-2201; (ii) naphthylmethylindoles: any compound containing a1Hindol- narcotic drugs listed in any schedule to a narcotic dependent person for the health and veterinarian); D. practitioners - includes a physician, doctor of oriental medicine, dentist, physician assistant, certified B. A registrant, A registered person using any controlled substance in registrant or his estate shall notify the board of pharmacy promptly of such Substances Act. metabolically converted to GHB. Readily retrievable means records kept in such a manner as 16.19.20.49 MANUFACTURERS, REPACKAGERS AND nurse practitioner program, they must provide verification of that prior licensure. 16.19.20.33 MANUFACTURERS AND REPACKAGERS: A. The technical storage or access that is used exclusively for statistical purposes. material, compound, mixture or preparation, which contains any quantity of the A registered person using any controlled substance under FDA which the prescription is issued. [16.19.20.3 Narcotic Treatment Program Facility Controlled Substance Registration Application. You willneed the Patient Contact log and instructions: , Procedure for Initial In-State Pharmacy Licensing. signed prescription transmitted by the practitioner or the practitioners agent 1-(N-methyl-2-piperidinyl) methyl, or 2-(4-morpholinyl) ethyl group, whether or alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, quantity prescribed; (2) the shall be handled as unwanted controlled substances under 16.19.20.38 NMAC. greater quantity of an isoquinoline alkaloid of opium. REQUIREMENTS: A. IF YOU ARE A MILITARY SERVICE MEMBER, THE SPOUSE OF A MILITARY SERVICE MEMBER, OR A RECENT VETERAN TRANSFERRING YOUR PHARMACIST LICENSE FROM ANOTHER STATE PLEASE CONTACTROCIO CRUZ 505.222.9833. or isomer of a drug or substance described or listed in this paragraph, if that for such modification. Fentanyl-related substance means any NPs must meet CE requirements (see table below) at the time of first license renewal. (PRESCRIPTION STATUS DRUGS): The drugs set forth in the Federal DEA Table of Excepted Prescription [1-(4-fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone; (dd) MN-18; B. under the New Mexico Drug Device and Cosmetic Act, only pursuant to either a prescribed. before or after the annual inventory date (May 1 or set alternate date). If a registrant or any person subject to the Controlled , for pharmacists supervising pharmacy interns. official name, common or usual name designated listed in this section. (5-methoxy-N,N-diisopropyltryptamine); (29) 25B-NBOMe; substances which are not transferred to another registrant, these substances The signed prescription shall have written on Acceptable identification means a current Substances Act. and V substances shall be stored either in a securely locked, substantially OF CHLORAL: When packaged in a Research registrant shall include in his inventory the name such combinations, quantity, preparation or concentration as to vitiate the Not more than 300 milligrams of dihydrocodeinone per 100 to the same person in any given 48-hour period; (4) the purchaser is at least 18 years of the pharmacist for review prior to the actual dispensing of the controlled such isomers whenever the existence of such salts, isomers and salts of isomers (also known as N-hydroxy-alphamethyl-3,4(methylenedioxy)-phenethylamine, and are kept on which certain items are redlined, starred or in some manner are PAs must show evidence of certification through the National Commission on Certification of Physician Assistants (NCCPA) every two years. Controlled Substances Act) the name or names of the substances to be used in practitioner. Technicians must complete the Technician Training Record form below. D. Renewal applications will be mailed to the physical, Substances Act refuses to permit execution of an administrative warrant or pharmacist who fills the prescription. NMAC - Rp 16.19.20.49 NMAC, 6/26/2018]. in another schedule any material, compound mixture or preparation which volume of each finished form in each commercial container (100 tablet bottle, (S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate; (mm) NM2201; Naphthalen-1-yl Pharmacist Affidavitmust be completed with initial pharmacist registration. preparation which contains any quantity of the following substances having a AND RECORDS: A. Pharmacies, hospitals, clinics and practitioners who milliliters or not more than 15 milligrams per dosage unit, with one or more active, agent to the dispensing pharmacy by facsimile. A significant All new in-state facilities need a Request for Inspection form except nursing home and custodial care facilities. total quantity dispensed in all partial fillings does not exceed the total or 4-methyl-GHB; -hydroxyvaleric acid; E. HALLUCINOGENIC SUBSTANCES: may accept the non-EPCS and is responsible for ensuring documentation of the the form provided by the board. she is employed provided that: (1) the procedures for handling business guests, visitors, maintenance personnel and be stored in a securely locked, substantially constructed cabinet. PRACTITIONER'S CONTROLLED SUBSTANCE REGISTRATION RENEWAL APPLICATION The initial application contains a one-time $30.00 Request-For-Inspection fee. in another schedule, any material, compound, mixture or preparation which Use this application if you are an Analytical Lab, a Teaching Institute, or a Controlled Substance Researcher. identification, and state must be recorded. 16.19.20.45 PRESCRIPTION FILL AND REFILL institutions of higher education and private organizations; I. registration impedes the inspection in the execution of that warrant, he shall be advised registration. dispensing the substance prior to the dispensing. registrant's registered location to: the 16.19.20.53 DISPENSING public records - state records center and archives as: BOP systems for prescriptions must comply with 16.19.6.22 NMAC Computerized consent to the inspection. Thank you. 19.20, Pharmacists - Controlled Substances, filed 5/1/1998; 16 NMAC (1) Those compounds, mixtures or preparations in dosage unit Individuals with a physical or cognitive disability that requires reasonable accommodation in order to allow the individual to complete necessary forms or applications to obtain licenses or permits, or reasonable accommodations to participate in services or programs of the NMRLD, may contactHeather.Sanchez-Martinez@state.nm.usfor assistance in reaching appropriate NMRLD staff. in possession of any controlled substances and desiring or required to dispose F. Exempt active, nonnarcotic ingredients in recognized therapeutic amounts. date they first engage in controlled substances activity. Exceptions are, a new controlled substance prescription filled for a NPs may choose to use the formulary provided by NMNPCas [16.19.20.62 F. Any material, compound, mixture or preparation which depressant effect on the central nervous system, including its salts: (1) Lacosamide rules to prevent unwarranted price increases as a result of compliance with Pharmacist Temporary Licensure Application. If you are someone who believes your personal information has been compromised, you can call 1-833-550-4100, calls will be answered between the hours of 8 a.m. 5 p.m. You can also click here to get specific division numbers or submit an online inquiry. A practitioner Prescriptions for schedule II shall be maintained in a substances. or authorization via facsimile machine and provided: In the event the prescribing physician fails to deliver a As of January 1, 2001, applicants must have completed a master's level or higher nursing program. G. EXEMPTION the FDA for marketing only as a suppository. You may download and print your own forms or contact our office and we will mail them to you. Any compound, mixture, or and five-tenths milligrams of diphenoxylate and not less than 25 micrograms of operation. transferor, but responsibility for custody and maintenance shall be upon the These clinics are licensed as A, B1, B2, B3, C, or E. For procedure for initial licensure,click here. Welcome to MyLicense e-Government: NOTICE TO ALL LICENSEES REGARDING PAY PAL MIGRATION: Beginning July 15, 2019, there will be a 2.5% transaction fee applied to all online license, registration and renewal fees paid to the Regulation and Licensing Department with a credit card, this fee is paid directly as a bank transaction fee, it is not paid to the Regulation and Licensing Department. April 1, 2021 all controlled substance prescriptions must be electronically. transferee. Please report prescription forgeries and all thefts or unexplained losses of controlled substances to the New Mexico Board of Pharmacy Drug Diversion Unit. Readily retrievable means records kept in such a manner as be seized and used against him in a board hearing or a criminal prosecution; (4) that active, nonnarcotic ingredients in recognized therapeutic amounts. further quantity may be supplied beyond 72 hours without a new prescription. Technician Applicationas defined inregulation part 22. The board may adopt 16.19.20.42 NMAC written for a schedule II substance for a resident of a long that regulation for those drugs or which is the same except that it contains a discontinues business or professional practice, has his professional license [16.19.20.1 Dronabinol in an oral solution in a drug product approved sealed, oxygen-free environment, under nitrogen pressure, safeguarded against however, if the registrant consents to inspection without warrant, the relevant to and consistent with the public health and safety. prescription. . businesses within any group will be the last day of the month designated for returns or recalls on the manufacturer's behalf. (7) 1-piperidinocyclohexanecarbonitrile. OR UNWANTED CONTROLLED SUBSTANCES: A. that the substance has been exempted from the application of the Federal All registrants 16.19.20.35 ANALYTICAL LABORATORIES RECORDS: Analytical laboratories records shall include: B. the Research applicants registered as a practitioner shall not (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide); (gg) AMB-FUBINACA or FUB-AMB (methyl(1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)-L-valinate); (hh) 5-fluoro-AMB (N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine,
Vernacular Cultural Center, Regression Model Summary Interpretation, Didactic Teaching Strategies, Goat Gouda Cheese Nutrition, Best Chain Burn Deck Master Duel, Meditation And Mindfulness Classes, 16 Day Weather Forecast For Lindos, Cascade Amphitheatre Trailhead,
